HOLLY ELZEY: Open Payments
NPI 1649532029 · THREE RIVERS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 46 payments from 11 companies in 2025. Trend: 2023 $155 · 2024 $1,236 · 2025 $837
Food & beverage: $837
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $196 |
| GlaxoSmithKline, LLC. | 11 | $178 |
| Lilly USA, LLC | 10 | $168 |
| Exact Sciences Corporation | 4 | $77 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Dexcom, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Abbott Laboratories | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: TRELEGY ELLIPTA, Ozempic, MOUNJARO, Cologuard Collection Kit, GEMTESA, Dexcom G6 Transmitter, Kerendia, KISUNLA.
Industry payments across TX — which companies pay providers there.
